What's It About?
With exclusive case studies and presentations on cutting-edge hit screening strategies across various target classes, take your chance to engage in in-depth discussions on tailoring screening approaches to your specific targets. Learn from industry leaders and peer experiences & explore how to customize strategies based on your chemical library needs. Discover how to leverage DNA-encoded libraries, high-throughput screening, AI, virtual screening, and fragment-based drug discovery for optimized hit identification and more accurate insights.
Join Your Peers to:
Ensure the reliability of your hits with PTC Therapeutics by implementing effective triage strategies to identify and correct false positives in your screening assays, optimizing resource use and efficiency
Explore advanced fragment-based drug discovery techniques with Vanderbilt University, targeting difficult molecules through innovative fragment and structure-based approaches
Collaborate with AstraZeneca and BPGbio to tackle "undruggable" targets by developing novel drug screening assays for targeted protein degradation (TPD) and molecular glue modalities
Gain fresh perspectives from Pfizer on the critical role of physiologically relevant cells and assays in structure-activity relationship (SAR) and high-throughput screening (HTS)
Join Bristol Myers Squibb and St. Jude Children's Research Hospital in exploring the strengths of phenotypic versus target-based screening methods and delve into effective target deconvolution strategies
Who Will You Meet?
The Hit ID Summit is providing the ideal environment for medicinal & discovery chemists from both large pharma & biotechs to unite, share experiences & reach conclusions to be applied in hit screening strategies.
Companies on the Program:
What Attendees from Events in the Series Have to Say:
“Right number of participants, high level of presentations from academy & industry, optimal time dedicated to presentations & networking. Very good organisation.”
GlaxoSmithKline, Structure Based Drug Design Summit
“Great networking opportunities, both reconnecting with old colleagues and meeting other biophysicists for the first time. The small size of the summit helped with this, and made idea exchange/discussion easier.”
Accent Therapeutics, Biophysics for Drug Discovery Summit
“The amalgamation of different approaches to tackle some of the most challenging biophysics problems was a standout for me. 1-1 interactions with different scientists and leaders from different companies was a great opportunity to exchange ideas”
Boehringer Ingelheim, Biophysics for Drug Discovery Summit